WBR0766: Difference between revisions

Jump to navigation Jump to search
No edit summary
m (refreshing WBR questions)
 
(7 intermediate revisions by 3 users not shown)
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}
|QuestionAuthor= {{YD}} (Reviewed by Will Gibson and  {{YD}})
|ExamType=USMLE Step 1
|ExamType=USMLE Step 1
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|MainCategory=Pathophysiology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|MainCategory=Pathology
|MainCategory=Pathophysiology
|SubCategory=Musculoskeletal/Rheumatology
|SubCategory=Musculoskeletal/Rheumatology
|Prompt=A 58 year old man, with a past medical history significant for small cell lung cancer (SCLC), presents to the physician's office complaining of proximal muscle weakness and eyelid ptosis. He explains that his lower extremities were first affected, but then his upper extremities were also involved. Physical examination is remarkable for motor weakness in the proximal extremities and tendinous areflexia. Electromyographic repetitive nerve stimulation using high-frequency stimulation shows an increment in compound muscle action potential amplitude. Which of the following is the most likely pathophysiology of the patient's condition?
|Prompt=A 58-year-old man with a recent diagnosis of small cell lung carcinoma (SCLC) presents to the physician's office with complaints of proximal muscle weakness and eyelid ptosis. He explains that his lower extremities were first affected, but then his upper extremities became involved. Physical examination is remarkable for tendinous areflexia. Electromyographic repetitive nerve stimulation using high-frequency stimulation demonstrates an increment in compound muscle action potential amplitude. What is the pathogenesis of the disease responsible for the patient's condition?
|Explanation=Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune neuromuscular disorder that may present in approximately half of the patients as a paraneoplastic syndrome in patients who have SCLC. LEMS is characterized by the presence of autoimmune antibodies against voltage-gated calcium channels (VGCC) that are located on the presynaptic nerve terminal.  
|Explanation=Lambert-Eaton myasthenic syndrome (LEMS) is a paraneoplastic, autoimmune neuromuscular disorder that is present in approximately half of patients with SCLC. LEMS is characterized by the formation of auto-antibodies against voltage-gated calcium (Ca++) channels (VGCC) on the pre-synaptic nerve terminal. Similar to myasthenia gravis (MG), LEMS is also a neuromuscular junction disease. However, LEMS is characterized by incremental improvement of the junction following repetitive stimulation, while MG is characterized by junctional fatigue (loss of action potential generation) following repetitive stimulation. LEMS typically manifests with proximal muscle weakness, which often starts in the lower extremities and progresses to involve the upper extremities. Similar to MG, ocular involvement is also common with LEMS. On physical examination, muscle weakness and tendinous areflexia are classic findings.
 
|AnswerA=Antibodies against the pre-synaptic sodium (Na+) channels
LEMS, similar to myasthenia gravis (MG), is also a neuromuscular junction disease. Unlike MG, LEMS is characterized by incremental improvement of the junction following repetitive stimulation. In contrast, MG is characterized by the opposite, where junctional fatigue and loss of action potential generation are seen following repetitive stimulation.
|AnswerAExp=Lambert-Eaton myasthenic syndrome (LEMS) is not caused by formation of antibodies against the pre-synaptic sodium (Na+) channels. The pre-synaptic sodium channels are normally responsible for depolarization of the pre-synaptic neuron of the neuromuscular junction.
 
|AnswerB=Antibodies against the pre-synaptic acetylcholine receptors
The most common presentation of patients with LEMS is proximal muscle weakness, that often starts in the lower extremities and soon progresses to involve the upper extremities. Ocular involvement, similar to patients with MG, is also frequently implicated in LEMS. On physical examination, muscle weakness and tendinous areflexia are common findings.
|AnswerBExp=LEMS is not caused by the formation of antibodies against the pre-synaptic acetylcholine receptors.
 
|AnswerC=Antibodies against post-synaptic acetylcholine receptors
Educational Objective: Lambert-Eaton myasthenic syndrome (LEMS) is characterized by formation of autoantibodies that target voltage-gated calcium channels (VGCC) in the pre-synaptic terminal of the neuromuscular junction.
|AnswerCExp=Myasthenia gravis is caused by formation of auto-antibodies against the post-synaptic acetylcholine receptors.
 
|AnswerD=Antibodies against pre-synaptic calcium (Ca++) channels
Reference:
|AnswerDExp=LEMS is caused by the formation of auto-antibodies against the pre-synaptic calcium (Ca++) channels.
Titulaer MJ, Lang B, Verschuuren J. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011; 10:1098-107.
|AnswerE=Antibodies against the post-synaptic calcium (Ca++) channels
|AnswerA=Antibodies against the pre-synaptic sodium (Na) channels
|AnswerEExp=LEMS is not caused by the formation of antibodies against post-synaptic calcium (Ca++) channels.
|AnswerAExp=Lambert-Eaton myasthenic syndrome (LEMS) is not due to formation of antibodies against the pre-synaptic sodium (Na) channels.
|EducationalObjectives=Lambert-Eaton myasthenic syndrome (LEMS) is characterized by formation of auto-antibodies that target voltage-gated calcium (Ca++) channels (VGCC) in the pre-synaptic terminal of the neuromuscular junction.
|AnswerB=Antibodies against the post-synaptic acetylcholine receptors
|References=Titulaer MJ, Lang B, Verschuuren J. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011; 10:1098-107.<br>
|AnswerBExp=Myasthenia gravis is due to formation of auto-antibodies against the post-synaptic acetylcholine receptors.
First Aid 2015 page 435
|AnswerC=Antibodies against the post-synaptic calcium (Ca) channels
|RightAnswer=D
|AnswerCExp=LEMS is not due to antibodies against the post-synaptic Ca channels.
|WBRKeyword=LEMS, Lambert-eaton myasthenic syndrome, Myasthenia gravis, Neuromuscular junction, VGCC, Voltage gated calcium channel, Autoimmune disease, Autoantibodies, Small cell lung carcinoma, SCLC, Paraneoplastic syndrome
|AnswerD=Antibodies against post-synaptic acetylcholine receptors
|Approved=Yes
|AnswerDExp=LEMS is not due to antibodies against post-synaptic acetylcholine receptors.
|AnswerE=Antibodies against pre-synaptic Ca channels
|AnswerEExp=LEMS is due to formation of auto-antibodies against the presynaptic calcium (Ca) channels.
|RightAnswer=E
|WBRKeyword=LEMS, lambert-eaton, myasthenia, myasthenic, syndrome, gravis, lambert, eaton, presynaptic, pre-synaptic, VGCC, voltage, gated, calcium, channel, channels, autoimmune, autoantibody, autoantibodies, auto-antibody, auto-antibodies, small, cell, lung, cancer, carcinoma, paraneoplastic, acetylcholine, receptor, receptors, antibody, antibodies
|Approved=No
}}
}}

Latest revision as of 01:38, 28 October 2020

 
Author [[PageAuthor::Yazan Daaboul, M.D. (Reviewed by Will Gibson and Yazan Daaboul, M.D.)]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pathophysiology
Sub Category SubCategory::Musculoskeletal/Rheumatology
Prompt [[Prompt::A 58-year-old man with a recent diagnosis of small cell lung carcinoma (SCLC) presents to the physician's office with complaints of proximal muscle weakness and eyelid ptosis. He explains that his lower extremities were first affected, but then his upper extremities became involved. Physical examination is remarkable for tendinous areflexia. Electromyographic repetitive nerve stimulation using high-frequency stimulation demonstrates an increment in compound muscle action potential amplitude. What is the pathogenesis of the disease responsible for the patient's condition?]]
Answer A AnswerA::Antibodies against the pre-synaptic sodium (Na+) channels
Answer A Explanation [[AnswerAExp::Lambert-Eaton myasthenic syndrome (LEMS) is not caused by formation of antibodies against the pre-synaptic sodium (Na+) channels. The pre-synaptic sodium channels are normally responsible for depolarization of the pre-synaptic neuron of the neuromuscular junction.]]
Answer B AnswerB::Antibodies against the pre-synaptic acetylcholine receptors
Answer B Explanation AnswerBExp::LEMS is not caused by the formation of antibodies against the pre-synaptic acetylcholine receptors.
Answer C AnswerC::Antibodies against post-synaptic acetylcholine receptors
Answer C Explanation AnswerCExp::Myasthenia gravis is caused by formation of auto-antibodies against the post-synaptic acetylcholine receptors.
Answer D AnswerD::Antibodies against pre-synaptic calcium (Ca++) channels
Answer D Explanation AnswerDExp::LEMS is caused by the formation of auto-antibodies against the pre-synaptic calcium (Ca++) channels.
Answer E AnswerE::Antibodies against the post-synaptic calcium (Ca++) channels
Answer E Explanation AnswerEExp::LEMS is not caused by the formation of antibodies against post-synaptic calcium (Ca++) channels.
Right Answer RightAnswer::D
Explanation [[Explanation::Lambert-Eaton myasthenic syndrome (LEMS) is a paraneoplastic, autoimmune neuromuscular disorder that is present in approximately half of patients with SCLC. LEMS is characterized by the formation of auto-antibodies against voltage-gated calcium (Ca++) channels (VGCC) on the pre-synaptic nerve terminal. Similar to myasthenia gravis (MG), LEMS is also a neuromuscular junction disease. However, LEMS is characterized by incremental improvement of the junction following repetitive stimulation, while MG is characterized by junctional fatigue (loss of action potential generation) following repetitive stimulation. LEMS typically manifests with proximal muscle weakness, which often starts in the lower extremities and progresses to involve the upper extremities. Similar to MG, ocular involvement is also common with LEMS. On physical examination, muscle weakness and tendinous areflexia are classic findings.

Educational Objective: Lambert-Eaton myasthenic syndrome (LEMS) is characterized by formation of auto-antibodies that target voltage-gated calcium (Ca++) channels (VGCC) in the pre-synaptic terminal of the neuromuscular junction.
References: Titulaer MJ, Lang B, Verschuuren J. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol. 2011; 10:1098-107.
First Aid 2015 page 435]]

Approved Approved::Yes
Keyword WBRKeyword::LEMS, WBRKeyword::Lambert-eaton myasthenic syndrome, WBRKeyword::Myasthenia gravis, WBRKeyword::Neuromuscular junction, WBRKeyword::VGCC, WBRKeyword::Voltage gated calcium channel, WBRKeyword::Autoimmune disease, WBRKeyword::Autoantibodies, WBRKeyword::Small cell lung carcinoma, WBRKeyword::SCLC, WBRKeyword::Paraneoplastic syndrome
Linked Question Linked::
Order in Linked Questions LinkedOrder::